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Heart fatty acid-binding protein (H-FABP) is present in a wide
variety of tissues but is found in the highest concentration in
cardiac and red skeletal muscle. It has been proposed that the
expression of H-FABP correlates directly with the fatty acid-
oxidative capacity of the tissue. In the present study, the
expression of H-FABP was measured in red and white skeletal
muscle under two conditions in which fatty acid utilization is
known to be increased: streptozotocin-induced diabetes and
fasting. Protein concentration, mRNA concentration and tran-
scription rate were measured under both conditions. The level of
INTRODUCTION
Fatty acid-binding proteins (FABPs) are a ubiquitously expressed
family of cytosolic proteins with a molecular mass ranging from
14 to 15 kDa. Although individual family members differ in
structure, tissue distribution and ligand specificity, they all share
the property of binding low-molecular-mass hydrophobic and
amphipathic ligands. At least ten unique family members have
been described, including gastrotropin, mammary-derived
growth inhibitor, five FABPs and three retinoid-binding proteins
(Ockner et al., 1992). FABPs bind fatty acids, their CoA and
carnitine esters and are thought to transport these ligands from
the plasma membrane to the interior of the cell for mitochondrial
and/or extramitochondrial oxidation (Veerkamp et al., 1991;
Ockner et al., 1992). Thus it has been suggested that FABPs may
be important in regulating fat oxidation.
Through peptide sequence analysis, the FABP found in skeletal
muscle was shown to be identical with heart FABP (H-FABP)
(Peeters et al., 1991). H-FABP has a wider tissue distribution
than the other FABPs, but is found in the highest concentration
in heart and red skeletal muscle (Heuckeroth et al., 1987;
Watanabe et al., 1991). Assessment of H-FABP expression in
various skeletal muscles suggests that the levels of both protein
(Crisman et al., 1987; Claffey et al., 1987; Miller et al., 1988;
Paulussen et al., 1989, 1990; Peeters et al., 1989; Veerkamp and
van Moerkerk, 1993) and mRNA (Heuckeroth et al., 1987;
Claffey et al., 1987) correspond to the red oxidative-fibre type
content in a given muscle. Thus it appears that the tissue
distribution of H-FABP seems to correspond with the degree to
which a tissue utilizes fatty acids as a fuel source (Glatz et al.,
1988; Veerkamp and van Moerkerk, 1993).
The cellular FABP level can be manipulated by various
physiological conditions and pharmacological treatments. For
example, liver FABP (L-FABP) increases 3-fold on high-fat diet,
starvation and administration of hypolipidaemic drugs such as
clofibrate (Bass, 1988; Veerkamp et al., 1991). In addition, the
both protein and mRNA increased approximately 2-fold under
each condition. The transcription rate was higher in red skeletal
muscle than in white muscle, was increased 2-fold during fasting,
but was unchanged by streptozotocin-induced diabetes. In ad-
dition to supporting the hypothesis that H-FABP is induced
during conditions ofincreased fatty acid utilization, these findings
demonstrate that the regulation of H-FABP expression may or
may not be at the level of transcription depending on the
stimulus.
myocardial H-FABP content can be modulated by the type of
dietary fat (Glatz et al, 1991), and both the myocardial and
skeletal H-FABP levels can be increased by exercise training or
testosterone treatment (Van Breda et al., 1992). In general,
metabolic situations that increase fatty acid oxidation result in
an increase in the level of FABP.
The aim of the present study was to investigate the effects of
streptozotocin (STZ)-induced diabetes and fasting on the level of
H-FABP in red and white skeletal muscle. Both of these
conditions have been shown previously to increase fatty acid
oxidation (Masoro, 1967; Schein et al., 1971), therefore we
hypothesized that these conditions would also increase the level
of H-FABP. In addition, we studied the mechanism of H-FABP
expression under these two metabolic conditions by determining
the steady-state mRNA level and rate of transcription originating
from the H-FABP gene.
MATERIALS AND METHODS
Materials
All radiolabelled compounds were purchased from Du Pont-New
England Nuclear. Hybond-N was obtained from Amersham
Corporation. RQ1 DNAase, RNAasin and all restriction
enzymes were purchased from Promega, Madison, WI, U.S.A.
All other chemicals unless otherwise specified were of molecular-
biology grade and purchased from Sigma or Fisher Scientific.
Animals and experimental design
Male Sprague-Dawley rats (300-350 g; CD strain, Charles River
Laboratories, Wilmington, MA, U.S.A.) were either made dia-
betic by a single intraperitoneal injection of 75 mg/kg STZ,
fasted for 3 days or maintained as controls. The STZ-induced
diabetic animals were killed 7 days after injection. Blood glucose
at the time of death averaged 543 + 13, 158 + 3 and 119 + 3 mg/dl
Abbreviations used: FABP(s), fatty acid-binding protein(s); H-FABP, heart fatty acid-binding protein; STZ, streptozotocin; fl-GPA, /J-guanidino-
propionic acid.
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for STZ-induced diabetic, fasted and control animals respect-
ively.
Antibody preparation
A peptide corresponding to the last 15 residues of the C-terminus
of rat H-FABP was synthesized and conjugated to keyhole
limpet haemocyanin. Then 500 ,tg of the peptide-keyhole limpet
haemocyanin conjugate was dissolved in 500 ,u of sterile 0.9%
NaCl and then emulsified with 500 1ul of Freund's complete
adjuvant. This was injected intramuscularly into three adult New
Zealand White rabbits. Three boosters of 500,g of conjugate
with incomplete adjuvant were given at 3-week intervals. After
3 weeks, a final 250 ,tg booster was given with incomplete
adjuvant. At 2 weeks after the final booster, blood was obtained
by intracardiac puncture, and incubated at 37 °C for 1 h. The
blood clot was loosened from the tube with a wooden stick and
incubated at 4 °C overnight. The blood clot was removed from
the tube carefully, after centrifugation at 5000 g (5000 rev./min)
for 10 min in an IEC Centa-7 centrifuge (International Equip-
ment Company); the resultant serum was utilized for Western
blotting without further purification.
Protein preparation and Western-blot analysis
After the rats had been killed, quadriceps from one hindlimb
were rapidly excised, red and white portions separated, frozen
with tongs cooled in liquid nitrogen, and stored at -70 °C until
analysis. After the muscle had been powdered using a cold steel
mortar and pestle, 100 mg of muscle was homogenized in 1 ml of
20 mM Hepes buffer containing 1 mM EDTA and 250 mM
sucrose using a Polytron (Brinkmann Instruments). The homo-
genate was centrifuged at 100000 g for 1 h at 4 °C in a Beckman
5OTi rotor. The protein concentration of the supernatant, con-
taining the cytosolic fraction, was determined using the bicin-
choninic acid assay from Pierce. Tricine/SDS/PAGE was per-
formed as described by Schagger and von Jagow (1987), in order
to maximize the resolution of low-molecular-mass proteins. The
system of Hjerten (1962), used to denote the composition of the
gels, defines T as the total percentage concentration of both
monomers (acrylamide and bisacrylamide) and C as the per-
centage concentration of the cross-linker relative to the total
concentration T. The 16.5% T/6% C separating gel and the 4%
T/3% C stacking gel both consisted of 1.0 M Tris, pH 8.45, and
0.1 % SDS. A separate anode buffer (0.2 M Tris, pH 8.9) and
cathode buffer (0.1 M Tris, 0.1 M tricine, 0.1 % SDS, pH 8.25)
were utilized. Electrophoresis was performed at 10 °C, starting at
30 V, and increasing to 105 V after the samples entered the
stacking gel, and continued for 16 h. Gels were electrically
transferred to Immobilon (Millipore) membrane at 0.25 A for
75 min. Gels were stained with Coomassie Blue to check the
completeness of transfer. Blots were blocked in 5 % (w/v) dried
milk and incubated with FABP antibody for 1 h at a 1:5000
dilution. Blots were washed in TBS (10 mM Tris/HCl, 0.9 %
NaCl, pH 7.4) and TBS/Tween [10 mM Tris/HCl, 0.9% NaCl,
0.05 % (v/v) Tween 20, pH 7.4] repeatedly, and then incubated
in donkey anti-rabbit-horseradish peroxidase conjugate antibody
for 1 h. Blots were washed in TBS and TBS/Tween again and
developed using the ECL (enhanced chemiluminescent) detection
system (Amersham). Adjustment of exposure time generated
films in the predetermined linear range. Resultant films were
quantified by densitometric scanning performed on a computer-
controlled laser densitometer (Ultrascan XL, LKB Pharmacia).
Absorbance units from densitometric scanning of multiple films
RNA isolation and Northern-blot analysis
Total RNA was isolated from 200 mg of the powdered red or
white quadriceps by the guanidinium thiocyanate/phenol/
chloroform extraction method (Chomczynski and Sacchi, 1987)
as modified by Puissant and Houdebine (1990). RNA (10l,g)
was denatured and size-fractionated on a 1.25% agarose/2.0 M
formaldehyde gel. After staining (0.5 ,ug/ml ethidium bromide),
the 28S and 18S ribosomal bands were visualized and photo-
graphed by u.v. transillumination to ensure that the RNA was
intact and evenly loaded. RNA was then transferred to Hybond-
N, u.v. cross-linked, and prehybridized at 47 °C for 4 h in a
solution of 50% (v/v) deionized formamide, 4 x SSC (1 x SSC =
150 mM NaCl, 15 mM sodium citrate), 5 x Denhardt's solution
(50 x Denhardt's = 0.1 0% each of BSA, poly(vinyl pyrrolidone)
and Ficoll], 0.1 mg/ml yeast tRNA, 50 mM sodium phosphate
(pH 7.0), 0.5 mg/ml sodium pyrophosphate and 10% SDS.
Hybridizations were carried out overnight in hybridization
solution (prehybridization solution with 1 x Denhardt's solution)
at 47 °C using the appropriate cDNA probe at 1 x 107 c.p.m./ml.
All cDNA probes were labelled with ka-32P]dATP (3000 Ci/
mmol) by random priming as previously described (Feinberg and
Vogelstein, 1983). Blots were washed for 30 min in 0.1 x SSC/
0.1 0% SDS at room temperature followed by 30 min at 55 °C,
and then subjected to autoradiography using Kodak XAR-5 film
with intensifying screens. The resulting autoradiograms were
quantified by densitometry.
Isolation of nuclei
Nuclei were isolated from rat skeletal muscle by a modified
procedure described by Zahradka et al. (1989). Quadriceps and
gastrocnemius/plantaris muscles were dissected, pooled, minced
and weighed (8-9 g). All procedures were carried out at 4 'C.
The tissue were then immediately homogenized with a Polytron
homogenizer in 31 vol. of lysis buffer (10 mM Hepes, pH 7.5,
5 mM KCl, 10 mM MgCl2, 5 mM 2-mercaptoethanol) containing
0.32 M sucrose. The homogenate was passed through four layers
of cheesecloth and filtered through a 100-mesh stainless-steel
screen (Fisher Scientific). Nuclei were collected by centrifugation
at 1000 g for 10 min in a Sorval GSA rotor. The nuclear pellet
was resuspended by gently triturating with 35 ml of lysis buffer
containing 2.2 M sucrose and centrifuged for 90 min at 80000 g
(27000 rev./min), in a Beckman SW28 rotor. The resulting
nuclear pellet was gently rinsed with lysis buffer and resuspended
in 2 ml of storage buffer (75 mM Hepes, pH 7.5, 60 mM KCl,
15 mM NaCl, 0.5 mM dithiothreitol, 0.1 mM EDTA, 0.1 mM
EGTA and 40% glycerol). The nuclei were repelleted by centri-
fugation for 10 min at 5000 g, in an IEC B-20A floor centrifuge,
and were resuspended by thoroughly triturating in 200 ,I of cold
storage buffer, transferred to Microfuge tubes and stored at
-80 'C until analysis.
Run-on transcription analysis
The procedure used for nuclear run-on analysis is based on
techniques previously described by Cornelius et al. (1990). After
thawing on ice, the concentration of DNA in each preparation
was determined by lysing-a 10 #1 portion in 990 ,,d of 0.1 % SDS
solution and measuring the absorbance at 260 and 230 nm (Kalb
et al., 1977). Equal numbers of nuclei from preparations from
control, STZ-diabetic and fasted rats were allowed to complete
the synthesis of nascent RNA transcripts in a reaction mixture
containing 58.7 mM Hepes, pH 7.5, SO.mM KCI, 11.7 mM NaCl,
6.5 mM dithiothreitol, 5 mM MgCl2, 78 ,gM EDTA, 78 ,uM
EGTA, 0.6 mM ATP, 0.3 mM GTP, 0.3 mM CTP and 0.4 ,uMwere normalized by inclusion of a rat heart standard on each gel.
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[a-32P]UTP (250 ,uCi/reaction) with 40 units of RNasin (RNAase
inhibitor) in a total volume of 230 #1 at 25 'C. After 30 min, the
samples were subjected to DNAase digestion for 5 min at 25 'C
by the addition of 25 units of RNAase-free DNAase followed by
the addition of 3 ml of a solution containing 4 M guanidinium
thiocyanate, 20 mM sodium acetate, pH 5.2, 0.5 % N-
laurylsarcosine and 5 % (v/v) 2-mercaptoethanol. The 32p_
labelled RNA was isolated by centrifugation (150000 g; 35000
rev./min) through 5.7 M CsCl (1.5 ml) in a Beckman SW55
rotor (16 h, 18 C).
The 32P-labelled RNA was recovered by resuspending the
pellet initially in 100,u of 10mM Tris/HCl, pH 7.4, buffer
containing 5.0 mM EDTA and 1% SDS at 65 'C followed by
three 100 u1 washes with diethylpyrocarbonate-treated water.
The RNA was recovered by ethanol precipitation and subjected
to DNAase digestion for 30 min at 37 'C with 10 units of
RNAase-free DNAase in 40 mM Tris/HCl, pH 7.6, buffer con-
taining 6.0 mM MgCl2, 10 mM NaCl, 1 mM dithiothreitol and
40 units of RNasin. The samples were extracted once with
chloroform/butanol (4: 1, v/v). To ensure complete denaturation
of the transcripts and to increase hybridization, the 32P-labelled
RNA was partially hydrolysed in 0.2 M NaOH (15 min on ice)
followed by neutralization with 1 M Hepes (pH 5.2) (Linial et
al., 1985). The 32P-labelled RNA was recovered by ethanol
precipitation and resuspended in 1 ml of hybridization solution
(see above) by heating at 65 'C for 10 min. The concentration of
32P-labelled RNA was determined by liquid-scintillation spec-
trometry, and all samples being compared were adjusted to equal
concentrations (c.p.m./ml) and volume (1 ml) with hybridization
solution. Hybridization was carried out using Hybond-N to
which 2 ,ug of several individual cDNAs of interest were fixed by
u.v. cross-linking. Each cDNA was gel-purified from its plasmid
vector after overnight digestion with the appropriate restriction
enzyme and then denatured in 0.1 M NaOH for 30 min at 37 'C,
neutralized in the presence of 10 x SSPE (1 x SSPE = 0.15 M
NaCl, 0.01 M NaHPO4, pH 7.4, and 1.0 mM EDTA), and
applied to Hybond-N using a slot-blot apparatus (Mini-fold II,
Schleicher and Schuell). All filters were prehybridized for 4 h at
47 'C in prehybridization solution (see above). Each filter for a
given RNA preparation was trimmed, cut in two and placed
back-to-back in a Seal-A-Meal bag (Dazey Corp.) to which the
1 ml of sample hybridization solution was added. This technique
permitted the detection of as many as 14 different transcripts
simultaneously. Hybridization was carried out for 2.5 days at
47 'C after which the filters were washed for 30 min at 50 'C in
2 x SSC, 30 min at 37 'C in 2 x SSC containing 10 ,ug/ml RNAase
A, and for 30 min at 55 'C in 0.1 x SSC/0.1 % SDS. After
drying, the membranes were subjected to autoradiography with
intensifying screens for 7-14 days. All bands were quantified by
laser densitometry.
Statistical analyses
All data are expressed as means + S.E.M. A one-way analysis of
variance was performed on all groups with the Dunnett's test
utilized to determine statistical differences. Significance was set
at the P < 0.05 level.
RESULTS
In a pilot study, the relationship between oxidative capacity and
the level of H-FABP was analysed in gastrocnemius muscles
obtained from a previous study in which oxidative capacity had
been increased by exercise training and/or treatment with fi-
guanidinopropionic acid (ft-GPA). ,-GPA is a drug that induces
mitochondrial biogenesis and increases fatty acid-oxidative
capacity in muscle. Muscles with a wide range of citrate syn-
thase activities (Srere, 1969) were chosen without respect for
the expenrmental group, and the level of H-FABP mRNA
was measured. Figure 1 shows positive correlation (r = 0.68,
P < 0.05) between citrate synthase activity and H-FABP
mRNA levels, indicating that H-FABP mRNA levels parallel the
increases in fatty acid-oxidative capacity in the muscle. These
results led to further investigation of the expression of H-FABP
during metabolic conditions that increase fatty acid oxidation.
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Figure 1 Correlation between H-FABP mRNA and citrate synthase activity
In gastrocnemius muscles
Whole gastrocnemius muscles with a wide range of oxidative capacities taken from a previous
experiment in which rats were exercise trained and/or treated with f8-GPA were analysed for
citrate synthase activity and H-FABP mRNA.
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Figure 2 Autoradlograms demonstrating Western-blot, Northern-blot and
run-on analyset of H-FABP In red and white quadriceps from control animals
Total protein and RNA were isolated from red and white portions of quadriceps and nuclei were
isolated from red and white portions of gastrocnemius/plantaris and quadriceps from control
rats. Each lane represents equal protein (20 ,ug of cytosolic protein), total RNA (10 ,ug), and
nascent RNA. In the nuclear run-on analyses, pGEM (non-specific plasmid DNA) was used as
a negative control, and all transcripts were normalized to genomic DNA to account for slight
variations in RNA transcript concentration in the hybridization solution. R, red skeletal muscle;
W, white skeletal muscle.
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Table 1 Effect of STZ-induced diabetes and fasting on H-FABP protein,
mRNA and transcriptlon rate
Values are means + S.E.M. relative to control (n = 7 for all three groups in the protein analysis,
n = 10 for all three groups in the mRNA analysis, n = 10 for control and diabetic groups and
n = 4 for the fasted group in the transcription analysis). * P < 0.05, compared with control.
Control Diabetic Fasted
H-FABP 1.00 + 0.28 1.80 + 0.27* 1.93 + 0.16*
H-FABP mRNA 1.00 + 0.20 2.34+ 0.14* 2.48 + 0.12*
H-FABP transcription rate 1.00 + 0.12 0.98 + 0.17 2.17 + 0.66
Protein
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Figure 3 H-FABP concentration, mRNA concentration and transcription
rate in red quadriceps from control, diabetic and fasted rats
Cytosolic proteins were isolated from red quadriceps from control (n = 7), 7-day STZ-diabetic
(n = 7) and 3-day fasted (n= 7) rats. Protein (20 ,g) was separated, transferred to
Immobilon, and probed with an H-FABP antibody as described in the Materials and methods
section. Total RNA was isolated from control (n = 10), 7-day STZ-diabetic (n = 10) and 3-day
fasted (n = 10) rats. RNA (15 ,gg) was separated, transferred to Hybond-N and hybridized with
an H-FABP cDNA probe. Nuclei were isolated from red gastrocnemius/plantaris and quadriceps
from control (n = 10), 7-day STZ-diabetic (n= 10) and 3-day fasted (n = 4) rats, and
subjected to run-on transcriptional analysis. C, control; D, 7-day STZ-diabetic; F, 3-day fasted.
P < 0.05) was probably due to the use of mixed muscle instead
of pure red skeletal muscle.
To test the hypothesis that H-FABP is induced during con-
ditions of increased fatty acid oxidation, male Sprague-Dawley
rats were injected with 0.75 mg STZ/kg body weight, fasted for
3 days or maintained as controls. Red and white quadriceps were
excised and freeze-clamped. Muscles were powdered and analysed
for H-FABP and its mRNA content by Western- and Northern-
blot analysis and H-FABP transcription rate by run-on analyses.
Figure 2 shows representative autoradiograms of these three
analyses, with each lane representing equal loads of protein,
mRNA or nascent RNA transcripts from either red or white
control skeletal muscle. Expression of H-FABP and its mRNA
was high in red skeletal muscle compared with the nearly
undetectable expression in white skeletal muscle. In agreement
with the protein and mRNA data, transcription of the H-FABP
gene was much greater in red than white skeletal muscle.
Table 1 summarizes the H-FABP, mRNA and transcription
run-on data from red skeletal muscle of control, STZ-induced
diabetic and fasted animals. Representative blots are shown in
Figure 3. Both STZ-induced diabetes and fasting resulted in a 2-
fold increase in H-FABP content. A similar trend was found for
mRNA content in all three groups. Although the level ofmRNA
was much lower in white muscle, the overall trends were identical
with those found in red muscle (results not shown).
In order to determine whether the increased levels of FABP
mRNA associated with STZ-induced diabetes and fasting origin-
ated at the level of transcription of the H-FABP gene, run-on
analyses were performed. Table 1 shows that there was no
change in the transcription rate in red skeletal muscle in response
to STZ-induced diabetes. However, fasting elicited a 2-fold
increase in the transcription rate of the H-FABP gene. The
effects of STZ-induced diabetes and fasting on the transcription
rate in white muscle could not be measured accurately because of
the nearly undetectable transcription rate.
DISCUSSION
The hypothesis that H-FABP is induced under conditions in
which fatty acid oxidation has been shown to increase was tested
under two conditions: STZ-induced diabetes and fasting in red
and white skeletal muscle. Red skeletal muscle differs from white
skeletal muscle in several ways, including higher capillary density,
oxidative enzyme content and mitochondrial density. These
inherent characteristics of red muscle account for its overall
higher respiratory capacity and ability to oxidize fatty acids
under both resting and exercise conditions. In contrast, white
skeletal muscle is characterized by a low respiratory capacity and
high glycogenolytic activity. If the function of H-FABP is to
transport fatty acids to the mitochondria for subsequent oxi-
dation, then it follows that red skeletal muscle should contain
more H-FABP than white skeletal muscle. Figure 2 confirms this
obvious difference in protein and mRNA levels between red and
white control skeletal muscle.
An increase in mRNA can be caused by an increase in the
transcription rate and/or an increase in mRNA stability. By
measuring the transcription rate of the H-FABP gene in red and
white skeletal muscle, we have shown that the greater amount of
H-FABP mRNA in red skeletal muscle can at least in part be
explained by a greater basal transcription rate.
To test the hypothesis that H-FABP expression is increased
under metabolic conditions that increase fatty acid oxidation,
rats were treated with STZ or were fasted for 3 days. Both of
these conditions have previously been shown to increase fatty
acid oxidation. The effect of STZ on H-FABP, its mRNA and
transcription rate in skeletal muscle has not previously been
reported. The effect of fasting on H-FABP of heart muscle was
studied by Paulussen et al. (1989), who showed an insignificant
decrease in tissue from fasted (66 h) animals compared with
control. In contrast with the results of Paulussen et al. (1989),
Table 1 shows that STZ-induced diabetes and fasting cause an
increase in H-FABP and mRNA levels. These findings support
the hypothesis that the synthesis of H-FABP is induced during
periods of increased fat oxidation.
Although both STZ-induced diabetes and fasting elicit an
increased expression of H-FABP, the two metabolic conditions
do so by different mechanisms. The increased mRNA levels
elicited by fasting are due, at least in part, to an increase in the
transcription ofthe H-FABP gene. In contrast with these findings,
STZ-induced diabetes does not increase the transcription rate of
this gene. These results imply that at least two mechanisms of
control can be employed in the regulation ofH-FABP expression,
one at the level of transcription and one possibly at the level of
mRNA stability.
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Unfortunately, the determination of H-FABP mRNA half-life
in skeletal muscle in vivo is very difficult for several reasons.
Because of the relatively low transcription rate of the H-FABP
gene in skeletal muscle, and the extreme abundance of H-FABP
mRNA in skeletal muscle reported by others (Claffey et al., 1987;
Heukeroth et al., 1987; Sarzani et al., 1988) and confirmed by
our laboratory, the turnover rate of the H-FABP message is
probably extremely low. Extended exposure times to transcrip-
tional inhibitors would allow phenomena such as extended
mRNA half-lives (Endo et al., 1973) and superinduction (Tom-
kins et al., 1972) to interfere with an accurate measurement of the
half-life. The complications caused by transcriptional inhibitors
injected into whole animals limits the type of messages for which
turnover rate can be accurately determined and certainly restricts
our ability to study the effects under altered metabolic conditions
such as STZ-induced diabetes. Because of the difficulties encoun-
tered in measuring mRNA half-lives in whole animals, most
studies utilize cell culture systems. As for H-FABP, we have been
unsuccessful in discovering a skeletal muscle cell line that contains
H-FABP.
In conclusion this study has shown that under conditions that
have previously been shown to induce fatty acid oxidation,
namely STZ-induced diabetes and fasting, the concentration of
H-FABP and its mRNA increased 2-fold. In addition, in the case
of red skeletal muscle compared with white muscle, and the
fasted group, the increase in mRNA can be explained, at least in
part, by an increase in the rate of transcription. However, in the
case of STZ-induced diabetes, an increase in transcription rate
cannot account for the increase in H-FABP mRNA. These
results imply that the expression of H-FABP in skeletal muscle
can be regulated at several levels including transcriptional
activation and probably mRNA stability. The details of these
unknown mechanisms of control are topics for further investig-
ations.
We gratefully acknowledge Dr. Jeffrey Gordon for his gift of the H-FABP cDNA. This
research was supported by grant ROl DK38416.
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